Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP613391.RABouXtm_Wdww5UAh-jiMuUl1SsHhFRU530YsCNSzMaNA130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613391.RABouXtm_Wdww5UAh-jiMuUl1SsHhFRU530YsCNSzMaNA130_provenance.
• NP602054.RAy9yNBZ5sjYTUtunlezdNkmpRa_qPsMOrm_VCyV1rC_0130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602054.RAy9yNBZ5sjYTUtunlezdNkmpRa_qPsMOrm_VCyV1rC_0130_provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP500538.RA9aH5KHrOsX1b2e1smIuVYiEAScATbr8op_9nmxQmzSM130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500538.RA9aH5KHrOsX1b2e1smIuVYiEAScATbr8op_9nmxQmzSM130_provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP362882.RAKUdrJH3k5EPI2PF2vwNmoe3jDauesUv9qeY7vj0SQxg130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362882.RAKUdrJH3k5EPI2PF2vwNmoe3jDauesUv9qeY7vj0SQxg130_provenance.
• NP937740.RA9VrFBQ9AAPiDiLg8GSihx6ZaPf81mzwm9b8-Nlglh8M130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937740.RA9VrFBQ9AAPiDiLg8GSihx6ZaPf81mzwm9b8-Nlglh8M130_provenance.
• NP593944.RAf7afF5UPyQa3S2NnF61Lsj0txNv3dhQyHevsBj7WAtI130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593944.RAf7afF5UPyQa3S2NnF61Lsj0txNv3dhQyHevsBj7WAtI130_provenance.
• NP360106.RAQugJUwT2LlcM1u5wyOVod7Acc6jjrQtT_E2L6md_kMY130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360106.RAQugJUwT2LlcM1u5wyOVod7Acc6jjrQtT_E2L6md_kMY130_provenance.
• NP782708.RAVSD1IV1ARyAcR7WxFwMYlQibq70luaEyHb21rLqAL60130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782708.RAVSD1IV1ARyAcR7WxFwMYlQibq70luaEyHb21rLqAL60130_provenance.
• NP855230.RAWUoNHx3Dx2JtYRH5hM9ufXMHkGtMZAUsGBXw6ELwpx8130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855230.RAWUoNHx3Dx2JtYRH5hM9ufXMHkGtMZAUsGBXw6ELwpx8130_provenance.
• NP929373.RAfehHbts5eFnBfMiZue0xl-2cx_FTqjPO7cNpyWEMTgw130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929373.RAfehHbts5eFnBfMiZue0xl-2cx_FTqjPO7cNpyWEMTgw130_provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.
• NP898504.RATmZx6k5JR4-o0Yrydj6mMAJVssQBQSNhMuTYoQsQ2zs130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898504.RATmZx6k5JR4-o0Yrydj6mMAJVssQBQSNhMuTYoQsQ2zs130_provenance.
• NP898506.RARTYKuPVQwqx-ttmqf_u3UhO-3kuiRV5fSV5CnkmQKLc130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898506.RARTYKuPVQwqx-ttmqf_u3UhO-3kuiRV5fSV5CnkmQKLc130_provenance.
• NP898508.RAS0tV2P1QBry80T6au-jxIqKrj74TFbQgS_9tZuJCUVA130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898508.RAS0tV2P1QBry80T6au-jxIqKrj74TFbQgS_9tZuJCUVA130_provenance.
• NP855090.RAvSAzWaQiXldNCDhfRpKz11sO0-o4ApZKEcM3-LgMADA130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855090.RAvSAzWaQiXldNCDhfRpKz11sO0-o4ApZKEcM3-LgMADA130_provenance.
• NP358508.RApekByfO6HwAp86Vs-wqA7snIxpcKwGkfB2DaUKrniP4130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358508.RApekByfO6HwAp86Vs-wqA7snIxpcKwGkfB2DaUKrniP4130_provenance.
• NP360103.RAiK-ifhj8BrOIR4Lpr0gXUydd5TzSaSAlXfXIwn7EzKw130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360103.RAiK-ifhj8BrOIR4Lpr0gXUydd5TzSaSAlXfXIwn7EzKw130_provenance.
• NP360250.RAv4l95BvoC4F69s3xcn5bxqAtTzDzejrmILd9G88ObGE130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360250.RAv4l95BvoC4F69s3xcn5bxqAtTzDzejrmILd9G88ObGE130_provenance.
• NP929378.RAtIdROQYOUrT7y_iI10JNqZ125XAM4SqQH19uaQYnqos130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929378.RAtIdROQYOUrT7y_iI10JNqZ125XAM4SqQH19uaQYnqos130_provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP593555.RAAiW0hRzdj9i0Ha_GtogCxIMsYhQWSvYkjpXYJt4y2lo130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593555.RAAiW0hRzdj9i0Ha_GtogCxIMsYhQWSvYkjpXYJt4y2lo130_provenance.
• NP898512.RAgjvVhcXrWQ2p3HiAE41zrJFoBRUSoxWHbZ5GQlyv2iY130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898512.RAgjvVhcXrWQ2p3HiAE41zrJFoBRUSoxWHbZ5GQlyv2iY130_provenance.
• NP358507.RA6PU9jIPQHJcCGgplc4jsiKKpuxj6rdh5i-2hbDzpRVI130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358507.RA6PU9jIPQHJcCGgplc4jsiKKpuxj6rdh5i-2hbDzpRVI130_provenance.
• NP593553.RA5kSNAdJAFumNkU3LPTQdaLaAL5sNw01vwFE9wCoKBy0130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593553.RA5kSNAdJAFumNkU3LPTQdaLaAL5sNw01vwFE9wCoKBy0130_provenance.
• NP358692.RAJ_m_EjWqtYsJrYzNHSRUtHl3ma8_IuHHItzOn6QR5Pc130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358692.RAJ_m_EjWqtYsJrYzNHSRUtHl3ma8_IuHHItzOn6QR5Pc130_provenance.
• NP898503.RAMtr0Kww4as3JzHIl6SxN-ZewSDljEn8lsJ4g_ruoKIw130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898503.RAMtr0Kww4as3JzHIl6SxN-ZewSDljEn8lsJ4g_ruoKIw130_provenance.
• NP782706.RA_VqRXujCKkeF9CYz7KcPdpT2QaDDejewGxUbVBc6EOc130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782706.RA_VqRXujCKkeF9CYz7KcPdpT2QaDDejewGxUbVBc6EOc130_provenance.
• NP782707.RA72oEHUV6qW4ykdd5OBHkxwBP0DeMjZHxhR5kGoz07Ts130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782707.RA72oEHUV6qW4ykdd5OBHkxwBP0DeMjZHxhR5kGoz07Ts130_provenance.
• NP855091.RA1pMoFnAKx3IfUv1Kw_OGP5Ywj51iwTOY4L6XWkAVXVk130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855091.RA1pMoFnAKx3IfUv1Kw_OGP5Ywj51iwTOY4L6XWkAVXVk130_provenance.
• NP929372.RA365PxONxnmCycssokykwvUO7PDf3snHgEqqtVC8sDvM130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929372.RA365PxONxnmCycssokykwvUO7PDf3snHgEqqtVC8sDvM130_provenance.
• NP898501.RA2wbN1diV9-L0OaPpRrKI1DJVdI-y2Rf6w6e1BQkLRfk130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898501.RA2wbN1diV9-L0OaPpRrKI1DJVdI-y2Rf6w6e1BQkLRfk130_provenance.
• NP898505.RA_HGm69arJhV2Gfr2MgS7Zs1yLktRibbeR2cKiEOz5dY130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898505.RA_HGm69arJhV2Gfr2MgS7Zs1yLktRibbeR2cKiEOz5dY130_provenance.
• NP898507.RA9Oxmu735u_u4aVM6lBNlDEDHWMJkzPJPnVwnGshUW0Y130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898507.RA9Oxmu735u_u4aVM6lBNlDEDHWMJkzPJPnVwnGshUW0Y130_provenance.
• NP898509.RA6J7nlX3MEllWoaZSLbV3yGRze4vtDdsbdW-ySvJrr3E130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898509.RA6J7nlX3MEllWoaZSLbV3yGRze4vtDdsbdW-ySvJrr3E130_provenance.
• NP898510.RAy0q_mU40gTEqWsfDpCV2pcEcqDAqamDzz5UJjJgzw1w130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898510.RAy0q_mU40gTEqWsfDpCV2pcEcqDAqamDzz5UJjJgzw1w130_provenance.
• NP898511.RA_eCSwt0SRn3sH0WNFlYEVWB-PtUCtUhN4oueKiYwSas130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898511.RA_eCSwt0SRn3sH0WNFlYEVWB-PtUCtUhN4oueKiYwSas130_provenance.